Press Releases

Nyxoah to present at the Oppenheimer 31st Annual Healthcare Conference

Mont-Saint-Guibert, Belgium – 24th February 2021 – Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the develop...

Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)

Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions ...

Nyxoah and Vanderbilt University enter exclusive licensing agreement regarding next generation neurostimulation technologies to treat Obstructive Sleep Apnea (OSA)

Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions ...

Nyxoah announces full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)

First US patient implanted in the DREAM pivotal IDE study, with the Genio® system for the treatment of Obstructive Sleep Apnea (OSA)

DREAM is a pivotal, Investigational Device Exemption (IDE) study, designed to support marketing authorization in the United States Nyxoah S.A. (EBR: NYXH)...

Nyxoah to Participate in Annual Piper Sandler Healthcare Conference

Nyxoah S.A. (EBR: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions and...

First Patient Implanted in the DREAM US Pivotal IDE Study, with the Genio® System for the Treatment of Obstructive Sleep Apnea (OSA)

DREAM is a pivotal, Investigational Device Exemption (IDE) study, designed to support marketing authorization in the United States. Nyxoah S.A. (EBR: NYXH...

Information on the total number of voting rights and shares

Transparancy release

In accordance with article 15 of the Act of 2nd May 2007 on the disclosure of large shareholdings, Nyxoah S.A. publishes the below information following the ...

Information on the total number of voting rights and shares

Transparancy release

In accordance with article 15 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah S.A. publishes the below information following the is...

Publication of transparency notifications

Transparancy release

In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA publishes the below information. It is to be noted...

bubble
bubble
bubble
bubble
bubble